FTO and nonpapillary renal cell carcinoma: In our study, we uncovered the vital role of FTO/YTHDF2/PDK1/m6A-dependent axis involved in the tumorigenesis and progression of ccRCC, which might provide potential therapeutic targets for ccRCC in the future.